Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ATOS Financial Statements and Analysis

NASDAQ : ATOS

Atossa Therapeutics, Inc.

$0.74
-0.0002-0.03%
At Close 4:00 PM
54.83
B-ESG ScoreESG Rating

ATOS FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

ATOS Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue00000
cost of revenue04.00K5.00K14.00K3.00K
gross profit0-4.00K-5.00K-14.00K-3.00K
gross profit ratio00000
research and development expenses3.412M3.553M3.748M5.654M4.467M
general and administrative expenses2.973M3.552M3.232M3.365K3.001M
selling and marketing expenses00-5.00K3.348M0
selling general and administrative expenses2.973M3.552M3.227M3.351M3.001M
other expenses00-36.00K0-35.00K
operating expenses6.385M7.105M6.975M9.005M7.468M
cost and expenses6.385M7.105M6.98M9.019M7.468M
interest income1.001M1.073M1.138M1.236M1.274M
interest expense00000
depreciation and amortization4.00K4.00K5.00K14.00K3.00K
ebitda-6.381M-7.101M-6.975M-9.005M-7.465M
ebitda ratio00000
operating income-6.385M-7.105M-6.98M-9.019M-7.468M
operating income ratio00000
total other income expenses net-845.00K1.056M1.102M1.265M-35.00K
income before tax-7.23M-6.049M-5.878M-7.754M-6.229M
income before tax ratio00000
income tax expense0000-1.274M
net income-7.23M-6.049M-5.878M-7.754M-6.229M
net income ratio00000
eps-0.058-0.048-0.047-0.062-0.05
eps diluted-0.058-0.048-0.047-0.062-0.05
weighted average shs out125.773M125.732M125.32M125.304M125.793M
weighted average shs out dil125.773M125.732M125.32M125.304M125.793M
Graph

ATOS Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents74.766M79.526M84.07M88.57M94.031M
short term investments00000
cash and short term investments74.766M79.526M84.07M88.57M94.031M
net receivables000028.00K
inventory01.095M1.372M03.582M
other current assets2.345M1.097M1.723M3.649M7.00K
total current assets77.111M81.718M87.055M92.219M97.648M
property plant equipment net00000
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments01.71M1.71M1.71M1.71M
tax assets00000
other non current assets2.366M2.43M2.322M2.323M2.337M
total non current assets2.366M4.14M4.032M4.033M4.047M
other assets001.0000
total assets79.477M85.858M91.087M96.252M101.695M
account payables1.561M1.056M1.23M806.00K718.00K
short term debt00000
tax payables00000
deferred revenue00000
other current liabilities4.235M4.64M4.098M4.43M2.726M
total current liabilities5.796M5.696M5.328M5.236M3.444M
long term debt00000
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities00000
total non current liabilities00000
other liabilities00000
capital lease obligations00000
total liabilities5.796M5.696M5.328M5.236M3.444M
preferred stock0000582.00K
common stock22.882M22.874M22.829M22.792M22.792M
retained earnings-205.445M-198.215M-192.166M-186.288M-178.534M
accumulated other comprehensive income loss0000254.886M
other total stockholders equity256.244M255.503M255.096M254.512M-1.475M
total stockholders equity73.681M80.162M85.759M91.016M98.251M
total equity73.681M80.162M85.759M91.016M98.251M
total liabilities and stockholders equity79.477M85.858M91.087M96.252M101.695M
minority interest00000
total investments01.71M1.71M1.71M1.71M
total debt00000
net debt-74.766M-79.526M-84.07M-88.57M-94.031M
Graph

ATOS Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
deferred income tax000-527.00K0
stock based compensation352.00K417.00K0926.00K1.603M
change in working capital1.16M756.00K1.65M1.417M769.00K
accounts receivables0028.00K709.00K1.00K
inventory002.544M-709.00K-1.00K
accounts payables-174.00K424.00K88.00K-304.00K-422.00K
other working capital1.334M332.00K-1.01M1.721M1.191M
other non cash items536.00K5.00K519.00K527.00K2.99M
net cash provided by operating activities-4.531M-4.698M-5.571M-3.883M-4.465M
investments in property plant and equipment-3.00K-6.00K0-1.00K-13.00K
acquisitions net00000
purchases of investments00000
sales maturities of investments00000
other investing activites00000
net cash used for investing activites-3.00K-6.00K0-1.00K-13.00K
debt repayment00000
common stock issued100.00K204.00K000
common stock repurchased00013.751M13.337M
dividends paid00000
other financing activites100.00K204.00K0-13.751M-13.337M
net cash used provided by financing activities100.00K204.00K0-1.475M13.337M
effect of forex changes on cash00019.11M4.478M
net change in cash-4.434M-4.50M-5.571M-5.359M-4.478M
cash at end of period79.636M84.07M88.57M94.141M99.50M
cash at beginning of period84.07M88.57M94.141M99.50M103.978M
operating cashflow-4.531M-4.698M-5.571M-3.883M-4.465M
capital expenditure-3.00K-6.00K0-1.00K-13.00K
free cash flow-4.534M-4.704M-5.571M-3.884M-4.478M
Graph

Frequently Asked Questions

How did Atossa Therapeutics, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?
A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, ATOS generated $0.00 in revenue last quarter, while its costs came in at $0.00.
Last quarter, how much Gross Profit did Atossa Therapeutics, Inc. report?
A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Atossa Therapeutics, Inc. reported a $0.00 Gross Profit for the quarter ended Jun 30, 2024.
Have ATOS's Total Operating Expenses and Operating Income been favorable recently?
Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. ATOS incurred $6.39M worth of Operating Expenses, while it generated -$6.39M worth of Operating Income.
How much Net Income has ATOS posted recently?
The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Atossa Therapeutics, Inc., the company generated -$7.23M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.
At the end of the last quarter, how much Cash and Equivalents did Atossa Therapeutics, Inc. have?
The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Atossa Therapeutics, Inc. as of the end of the last quarter was $74.77M.
What are ATOS's Total Net Receivables for the last quarter?
Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, ATOS had Total Net Receivables of $0.00.
In terms of Total Assets and Current Assets, where did Atossa Therapeutics, Inc. stand at?
An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of ATOS were $77.11M, while the Total Assets stand at $79.48M.
As of the last quarter, how much Total Debt did Atossa Therapeutics, Inc. have?
The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of ATOS's debt was $0.00 at the end of the last quarter.
What were ATOS's Total Liabilities during the last reported quarter?
A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, ATOS reported total liabilities of $5.80M.
How much did ATOS's Working Capital change over the last quarter?
Working Capital Change for ATOS was $1.16M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.
ATOS generated how much cash from operating activities?
An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. ATOS generated -$4.53M of Cash from Operating Activities during its recently reported quarter.
What was ATOS's latest reported Net Change in Cash?
An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. ATOS reported a -$4.43M Net Change in Cash in the most recent quarter.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph